CAR T-cell therapy is a type of gene therapy where the patient’s T-lymphocytes are genetically altered to target cancer cells within the patient’s body.
Meet William Tse division director of hematology and oncology at MetroHealth in Cleveland. He has a passion for oncology and is focused on collaboration
Fred Hutch researchers have launched a clinical trial for patients with HIV who need a transplant to survive advanced leukemia. They will receive a transplant of cord blood from donors who have a rare genetic trait that confers resistance to HIV, in hopes of curing both leukemia and HIV. The protocol is similar to that used in 2017 with a New York patient who last month was declared the third person ever cured of HIV.
Spotlight on Scott Furlan
Scott Furlan, pediatric oncologist
Dr. Scott Furlan, a pediatric oncologist at Fred Hutchinson Cancer Research Center, believes he was drawn to bone marrow transplantation because of the sheer complexity of the challenge.
“In pediatric transplant, each patient has a dizzying array of complex problems, each of which often has multiple solutions” Furlan said.
To treat his young cancer patients, he has to sort through raft of possibilities and options, while helping parents navigate the frightful choices that lie ahead of them.
“In pediatrics, we have the opportunity to develop long-lasting relationships and extraordinary connections with patients and families. I still talk with many patients and their parents a decade later,” Furlan said.